Literature DB >> 11682232

Determination of aceclofenac in bulk and pharmaceutical formulations.

N H Zawilla1, M Abdul Azim Mohammad, N M El Kousy, S M El-Moghazy Aly.   

Abstract

Three sensitive and reproducible methods for quantitative determination of aceclofenac (AC) in pure form and in pharmaceutical formulation are presented. The first method is based on the reaction between the drug via its secondary aromatic amino group and p-dimethylaminocinnamaldehyde (PDAC) in acidified methanol to give a stable coloured complex after heating at 75 degrees C for 20 min. Absorption measurements were carried out at 665.5 nm. Beer's law is obeyed over concentration range 20-100 microg ml(-1) with mean recovery 100.33 +/- 0.84. The other two methods are high performance liquid chromatography (HPLC) and densitometric methods by which the drug was determined in the presence of its degradation products over concentration range of 20-70 microg ml(-1) and 1-10 microg per spot and mean recoveries are 99.59 +/- 0.90 and 99.45 +/- 1.09, respectively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11682232     DOI: 10.1016/s0731-7085(01)00518-0

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac.

Authors:  Ambarish H Vadher; Jolly R Parikh; Rajesh H Parikh; Ajay B Solanki
Journal:  AAPS PharmSciTech       Date:  2009-05-15       Impact factor: 3.246

2.  Study of efficiency and spectral resolution for mathematical filtration technique using novel unlimited derivative ratio and classical univariate spectrophotometric methods for the multicomponent determination-stability analysis.

Authors:  Hayam Mahmoud Lotfy; Dina Abbas Ahmed; Mohamed Khaled Abdel Rahman; Soheir Abdel Fattah Weshahy
Journal:  Heliyon       Date:  2019-05-09

3.  Simple spectrophotometric methods for estimation of aceclofenac from bulk and formulations.

Authors:  A Bose; Pp Dash; Mk Sahoo
Journal:  Pharm Methods       Date:  2010-10

4.  Development and validation of UV-Visible spectrophotometric baseline manipulation methodology for simultaneous analysis of drotraverine and etoricoxib in pharmaceutical dosage forms.

Authors:  Vishnu P Choudhari; Sanket R Parekar; Subhash G Chate; Pradeep D Bharande; Bhanudas S Kuchekar
Journal:  Pharm Methods       Date:  2011-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.